Board of Directors

The Novartis Board of Directors is responsible for the direction, strategy, organization and administration of the company. The Board comprises 13 members with Joerg Reinhardt as chair.

Download the Board of Director Committee Organizational Chart (PDF 0.1 MB)

Joerg Reinhardt, Ph.D., Chairman of the Board of Directors

Chair

Joerg Reinhardt, Ph.D.

Simon Moroney, Member of the Board of Directors

Board member since February 28, 2020 | Vice Chair since March 4, 2022

Simon Moroney, D.Phil.

Nancy C. Andrews, M.D., Ph.D., Member of the Board of Directors

Board member since 2015

Nancy C. Andrews, M.D., Ph.D.

Ton Buechner, Member of the Board of Directors

Board member since 2016

Ton Buechner

Patrice Bula, Member of the Board of Directors

Board member since February 28, 2019 | Lead Independent Director since March 4, 2022

Patrice Bula

Elizabeth (Liz) Doherty, Member of the Board of Directors

Board member since 2016

Elizabeth (Liz) Doherty

Bridgette Heller, Member of the Board of Directors

Board member since February 28, 2020

Bridgette Heller

Daniel Hochstrasser

Member of the Board of Directors since March 4, 2022

Daniel Hochstrasser

Frans van Houten, Member of the Board of Directors

Board member since 2017

Frans van Houten

Andreas von Planta, Ph.D., Member of the Board of Directors

Board member since 2006

Andreas von Planta, Ph.D.

Ana de Pro Gonzalo

Board member since March 4, 2022

Ana de Pro Gonzalo

Charles L. Sawyers, M.D., Member of the Board of Directors

Board member since 2013

Charles L. Sawyers, M.D.

William T. Winters, Member of the Board of Directors

Board member since 2013

William T. Winters

Charlotte Pamer-Wieser, Ph.D., Corporate Secretary

Corporate Secretary

Charlotte Pamer-Wieser, Ph.D.